"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 12 | 12 |
| 1998 | 0 | 17 | 17 |
| 1999 | 0 | 27 | 27 |
| 2000 | 0 | 22 | 22 |
| 2001 | 0 | 29 | 29 |
| 2002 | 0 | 25 | 25 |
| 2003 | 0 | 49 | 49 |
| 2004 | 0 | 33 | 33 |
| 2005 | 0 | 45 | 45 |
| 2006 | 0 | 43 | 43 |
| 2007 | 0 | 55 | 55 |
| 2008 | 0 | 45 | 45 |
| 2009 | 4 | 50 | 54 |
| 2010 | 4 | 62 | 66 |
| 2011 | 9 | 64 | 73 |
| 2012 | 5 | 68 | 73 |
| 2013 | 4 | 67 | 71 |
| 2014 | 6 | 66 | 72 |
| 2015 | 11 | 89 | 100 |
| 2016 | 6 | 74 | 80 |
| 2017 | 8 | 89 | 97 |
| 2018 | 6 | 90 | 96 |
| 2019 | 10 | 110 | 120 |
| 2020 | 6 | 85 | 91 |
| 2021 | 7 | 66 | 73 |
| 2022 | 0 | 39 | 39 |
| 2023 | 0 | 46 | 46 |
| 2024 | 20 | 36 | 56 |
| 2025 | 6 | 44 | 50 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis. J Neurol Neurosurg Psychiatry. 2025 Oct 15; 96(11):1046-1052.
-
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. Am J Respir Crit Care Med. 2025 Oct; 211(10):1794-1801.
-
IMI-Interventions for Controlling Myopia Onset and Progression 2025. Invest Ophthalmol Vis Sci. 2025 Sep 02; 66(12):39.
-
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study. Diabetes Care. 2025 Sep 01; 48(9):1571-1580.
-
Divergent Roles of C/EBP? Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple-Negative Breast Cancer. FASEB J. 2025 Aug 31; 39(16):e70984.
-
Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Nov; 12(6):e200466.
-
Development and Preliminary Validation of Standardized Regression-Based Change Scores as Measures of Transitional Cognitive Decline. Arch Clin Neuropsychol. 2025 Aug 25; 40(6):1146-1157.
-
Prevalence, Severity, and Progression of Cerebellar Cognitive-Affective Syndrome in Patients With Spinocerebellar Ataxias. Neurology. 2025 Sep 09; 105(5):e213980.
-
Successful Treatment of Double-Positive Rapidly Progressive Glomerulonephritis: A Case Report. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251365418.
-
Differences in Patient and Parent Preferences for Prognostic Communication Across Disease Milestones in Advanced Childhood Cancer. Pediatr Blood Cancer. 2025 Nov; 72(11):e31964.